Cargando…
Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
INTRODUCTION: Neoadjuvant chemotherapy (NACT), which is standard treatment for locally advanced breast cancer, improves the resectability of patients with early breast cancer and reduces the extent of breast and axillary surgery. Caveolin-1 (CAV1) is implicated in human cancers, although its utility...
Autores principales: | Ye, Jia-Hui, Shi, Jia-Jun, Yin, Xi, Wu, Hong-Yan, Xu, Xin-Yun, Yao, Yong-Zhong, Zhang, Wei-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519866/ https://www.ncbi.nlm.nih.gov/pubmed/33061584 http://dx.doi.org/10.2147/CMAR.S264673 |
Ejemplares similares
-
High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma
por: Liang, Aijun, et al.
Publicado: (2021) -
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?
por: Yao, Liqin, et al.
Publicado: (2022) -
Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
por: Wu, Yanan, et al.
Publicado: (2017) -
Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma
por: Dong, Xiaogang, et al.
Publicado: (2017) -
SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer
por: Zhao, Weipeng, et al.
Publicado: (2021)